Weight Loss Stopped on Ozempic, Wegovy, or Zepbound? GLP-1 Plateau Troubleshooter
Find out whether you've hit a true plateau, an expected one, or a fixable one, and which changes are most likely to get the scale moving again on semaglutide, tirzepatide, the Wegovy pill, or Foundayo.
Diagnose your plateau
Your habits and situation
Your most likely levers, in order
Bring these to your prescriber
This is exactly what coaching fixes. Most plateaus come down to two or three habits that are hard to see from the inside. In a free 30-minute session, I'll find yours and build a plan to restart fat loss without losing muscle.
Book a free intro sessionEducational only. Never change your medication or dose without talking to your prescriber.
Why does weight loss stop on a GLP-1?
Every GLP-1 medication eventually produces a plateau. In the major trials, average weight loss slowed and leveled off after about a year to a year and a half: around 15% on semaglutide 2.4 mg in STEP 1, and up to about 21% on tirzepatide in SURMOUNT-1. That isn't the medication failing. It's your body reaching a new balance between appetite and energy use.
Two forces drive it. First, a smaller body burns fewer calories. Second, appetite pushes back as you lose weight. Research quantifying this feedback estimates that appetite increases by roughly 100 calories per day for every kilogram lost, which is far larger than the drop in calorie burn. GLP-1 medications blunt that appetite signal, but not indefinitely and not completely.
Is it a real plateau or just water?
A scale that's flat for one to three weeks usually isn't a plateau. Water shifts from salt, carbohydrates, hard workouts, constipation (common on GLP-1s), and the menstrual cycle can hide several pounds of fat loss. Look at your weekly average weight over at least three to four weeks before deciding anything has stalled.
If you've started strength training, your waist may keep shrinking while the scale stalls. That's body recomposition, and it's a good outcome. Measure your waist at the navel every two weeks.
The most common fixable causes of a GLP-1 plateau
Liquid calories
GLP-1 medications reduce hunger for food much more reliably than they reduce intake of drinks. Alcohol, specialty coffee drinks, juice, and smoothies can add several hundred calories a day without triggering fullness. This is often the fastest fix.
Appetite returning
Food noise often creeps back after months on the same dose. If it has, the conversation with your prescriber about dose is legitimate, but structure matters just as much: planned meals built around protein, fewer grazing opportunities, and no "free" evenings.
Low protein and no strength training
Without resistance training and enough protein, a larger share of weight lost can come from muscle, and muscle is what keeps your calorie burn up. People who protect muscle lose more fat for the same scale change and plateau later. The GLP-1 protein calculator gives you a daily target.
Weekend and evening drift
Five disciplined days and two loose ones can erase a weekly deficit entirely. On a GLP-1, the deficit is smaller than it feels, so the margin for error is thin.
Sleep
Short sleep increases hunger and cravings. In controlled studies of dieting, cutting sleep shifted weight loss away from fat and toward lean tissue.
Missed doses or wrong timing
Late or skipped injections let appetite rebound. With the Wegovy pill, taking it with coffee, food, or other pills, or not waiting 30 minutes, reduces absorption and can quietly lower its effect. Foundayo has no timing restrictions.
Medications and medical causes
Several common medications promote weight gain or make loss harder, including corticosteroids, insulin, sulfonylureas, many antipsychotics, and some antidepressants and mood stabilizers. An underactive thyroid can also slow progress. These are worth reviewing with your prescriber rather than troubleshooting alone.
When a plateau is expected
If you've been on your medication for a year or more and lost close to the average from its trial, you may simply have reached your set point on that drug. At that stage, the goal shifts from losing more weight to improving body composition (more muscle, less fat at the same weight) and keeping the loss off. That's where strength training and a structured eating pattern pay off most.
Frequently asked questions
Why did I stop losing weight on Zepbound?
The most common reasons are returning appetite, liquid calories, looser weekends, and not having reached your full dose. After about a year, a plateau near 20% weight loss is also expected, since that's where average weight loss leveled off in the SURMOUNT-1 trial.
How long does a plateau on Ozempic last?
A short stall of 1 to 3 weeks is usually water and resolves on its own. A true plateau lasts until something changes: your intake, your activity, your dose, or your goal.
Should I increase my dose if I hit a plateau?
That's a decision for your prescriber. If you aren't on the highest planned dose, ask whether increasing it is appropriate. Never adjust your dose on your own.
Can strength training cause a weight loss plateau?
It can make the scale stall while your waist keeps shrinking, because you're gaining muscle while losing fat. That's progress. Track your waist and how your clothes fit.
Does eating too little cause a plateau on a GLP-1?
Eating very little doesn't stop fat loss, but it can increase muscle loss and make the eventual rebound harder to manage. Prioritize protein and strength training over eating less.
Is a plateau a sign the medication stopped working?
No. The medication is still suppressing appetite. A plateau usually means you've reached a new balance, and the medication is now helping you hold that weight.
References
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
- Polidori D, Sanghvi A, Seeley RJ, Hall KD. How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake. Obesity. 2016;24(11):2289-2295.
- Nedeltcheva AV, et al. Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med. 2010;153(7):435-441.
- Apovian CM, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362.
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory. Am J Clin Nutr. 2025;122(1):344-367.